1. Home
  2. AVXL vs LQDT Comparison

AVXL vs LQDT Comparison

Compare AVXL & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • LQDT
  • Stock Information
  • Founded
  • AVXL 2004
  • LQDT 1999
  • Country
  • AVXL United States
  • LQDT United States
  • Employees
  • AVXL N/A
  • LQDT N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • LQDT Catalog/Specialty Distribution
  • Sector
  • AVXL Health Care
  • LQDT Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • LQDT Nasdaq
  • Market Cap
  • AVXL 716.1M
  • LQDT 755.4M
  • IPO Year
  • AVXL N/A
  • LQDT 2006
  • Fundamental
  • Price
  • AVXL $9.24
  • LQDT $31.48
  • Analyst Decision
  • AVXL Strong Buy
  • LQDT Strong Buy
  • Analyst Count
  • AVXL 2
  • LQDT 2
  • Target Price
  • AVXL $43.00
  • LQDT $38.50
  • AVG Volume (30 Days)
  • AVXL 1.4M
  • LQDT 321.7K
  • Earning Date
  • AVXL 02-05-2025
  • LQDT 12-12-2024
  • Dividend Yield
  • AVXL N/A
  • LQDT N/A
  • EPS Growth
  • AVXL N/A
  • LQDT N/A
  • EPS
  • AVXL N/A
  • LQDT 0.63
  • Revenue
  • AVXL N/A
  • LQDT $363,318,000.00
  • Revenue This Year
  • AVXL N/A
  • LQDT $31.09
  • Revenue Next Year
  • AVXL N/A
  • LQDT N/A
  • P/E Ratio
  • AVXL N/A
  • LQDT $48.65
  • Revenue Growth
  • AVXL N/A
  • LQDT 15.54
  • 52 Week Low
  • AVXL $3.25
  • LQDT $13.99
  • 52 Week High
  • AVXL $10.45
  • LQDT $36.00
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 62.34
  • LQDT 65.13
  • Support Level
  • AVXL $7.93
  • LQDT $30.27
  • Resistance Level
  • AVXL $9.48
  • LQDT $36.00
  • Average True Range (ATR)
  • AVXL 0.65
  • LQDT 1.40
  • MACD
  • AVXL -0.01
  • LQDT 0.61
  • Stochastic Oscillator
  • AVXL 72.28
  • LQDT 57.40

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

Share on Social Networks: